À propos de cet article

Citez

1. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994; 266(5182): 66-71.10.1126/science.7545954Search in Google Scholar

2. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995; 378(6559): 789-792.10.1038/378789a0Search in Google Scholar

3. Walsh T, King MC. Ten genes for inherited breast cancer. Cancer Cell. 2007; 11(2): 103-5.10.1016/j.ccr.2007.01.010Search in Google Scholar

4. Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007; 7(12): 937-948.10.1038/nrc2054Search in Google Scholar

5. Ferla R, Calo V, Cascio S, et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007; 18 (Suppl 6): vi93-98.10.1093/annonc/mdm234Search in Google Scholar

6. Balmana J, Diez O, Castiglione M. BRCA in breast cancer: ESMO clinical recommendations. Ann Oncol. 2009; 20(Suppl 4): 19-20.10.1093/annonc/mdp116Search in Google Scholar

7. De Greve J, Sermijn E, De Brakeleer S, Ren Z, Teugels E. Hereditary breast cancer: from bench to bedside. Curr Opin Oncol. 2008; 20(6): 605-613.10.1097/CCO.0b013e3283139173Search in Google Scholar

8. Rouleau M, Patel A, Hendzel MJ, Kaufmann SH, Poirier GG. PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010; 10(4): 293-301.10.1038/nrc2812Search in Google Scholar

9. Byrski T, Gronwald J, Huzarski T, et al. Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy. J Clin Oncol. 2010; 28(3): 375-379.10.1200/JCO.2008.20.7019Search in Google Scholar

10. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2000; 2(2): 77-81.10.1186/bcr36Search in Google Scholar

11. Freedman ML, Penney KL, Stram DO, et al. A haplotype- based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res. 2005; 65(16): 7516-7522.10.1158/0008-5472.CAN-05-0132Search in Google Scholar

12. Ewald IP, Ribeiro PL, Palmero EI, Cossio SL, Giugliani R, Ashton-Prolla P. Genomic rearrangements in BRCA1 and BRCA2: A literature review. Genet Mol Biol. 2009; 32(3): 437-446.10.1590/S1415-47572009005000049Search in Google Scholar

13. Cox DG, Kraft P, Hankinson SE, Hunter DJ. Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer. Breast Cancer Res. 2005; 7(2): R171-R175.10.1186/bcr973Search in Google Scholar

14. Qiu LX, Yao L, Xue K, et al. BRCA2 N372H polymorphism and breast cancer susceptibility: a metaanalysis involving 44,903 subjects. Breast Cancer Res Treat. 2010; 123(2): 487-490. 10.1007/s10549-010-0767-5Search in Google Scholar

ISSN:
1311-0160
Langue:
Anglais
Périodicité:
2 fois par an
Sujets de la revue:
Medicine, Basic Medical Science, other